Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
AOCS Annual MeetingAOCS Annual Meeting
Not Confirmed
Not Confirmed
27-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
AOCS Annual MeetingAOCS Annual Meeting
Industry Trade Show
Not Confirmed
27-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
16 Apr 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/rising-pharma-gets-final-approval-from-usfda-for-mesalamine-suppositories-1000-mg-17029
26 Mar 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-26-2025-60230.pdf
15 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf
13 Sep 2024
// BUSINESSWIRE
07 Jun 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218283
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217412
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABIRATERONE ACETATE
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-02-25
Application Number : 208371
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : POWDER;INTRAVENOUS
Brand Name : ACETAMINOPHEN
Dosage Strength : 1GM/VIAL
Packaging :
Approval Date : 2021-01-15
Application Number : 206610
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Brand Name : TRAMADOL HYDROCHLORIDE AN...
Dosage Strength : 325MG;37.5MG
Packaging :
Approval Date : 2008-09-26
Application Number : 77858
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE, EXTENDED RELEAS...
Brand Name : ACETAZOLAMIDE
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-06-18
Application Number : 203917
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION/DROPS;OTIC
Brand Name : ACETIC ACID
Dosage Strength : 2%
Packaging :
Approval Date : 2018-03-09
Application Number : 207280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : ACETYLCYSTEINE
Dosage Strength : 6GM/30ML (200MG/ML)
Packaging :
Approval Date : 2015-03-24
Application Number : 203173
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : ACETYLCYSTEINE
Dosage Strength : 6GM/30ML (200MG/ML)
Packaging :
Approval Date :
Application Number : 203624
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;INTRAVENOUS
Brand Name : ADENOSINE
Dosage Strength : 90MG/30ML (3MG/ML)
Packaging :
Approval Date : 2014-10-02
Application Number : 90450
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : ADENOSINE
Dosage Strength : 3MG/ML
Packaging :
Approval Date : 2008-10-31
Application Number : 78076
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;INTRAVENOUS
Brand Name : ADENOSINE
Dosage Strength : 60MG/20ML (3MG/ML)
Packaging :
Approval Date : 2014-10-02
Application Number : 90450
Regulatory Info : RX
Registration Country : USA
ABOUT THIS PAGE